NI201600077A -
PHARMACOLOGICAL ADMINISTRATION SYSTEM
- Google Patents
PHARMACOLOGICAL ADMINISTRATION SYSTEM
Info
Publication number
NI201600077A
NI201600077ANI201600077ANI201600077ANI201600077ANI 201600077 ANI201600077 ANI 201600077ANI 201600077 ANI201600077 ANI 201600077ANI 201600077 ANI201600077 ANI 201600077ANI 201600077 ANI201600077 ANI 201600077A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=59858328&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NI201600077(A)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Sharp And Dohme B VfiledCriticalMerck Sharp And Dohme B V
Publication of NI201600077ApublicationCriticalpatent/NI201600077A/en
En el presente documento se describe un sistema de administración farmacológico intravaginal que comprende (i) un núcleo que comprende un primer polímero termoplástico y un primer agente terapéutico, en el que el primer agente terapéutico se disuelve en el primer polímero termoplástico, y (ii) una capa externa que rodea el núcleo que comprende un segundo polímero termoplástico, en el que el primer agente terapéutico es menos permeable en el segundo polímero termoplástico que el primer polímero termoplástico, y un segundo agente terapéutico en forma sólida, en el que el segundo agente terapéutico está cargado en una porción de la capa externa.Described herein is an intravaginal drug delivery system comprising (i) a core comprising a first thermoplastic polymer and a first therapeutic agent, wherein the first therapeutic agent is dissolved in the first thermoplastic polymer, and (ii) an outer layer surrounding the core comprising a second thermoplastic polymer, in which the first therapeutic agent is less permeable in the second thermoplastic polymer than the first thermoplastic polymer, and a second therapeutic agent in solid form, in which the second agent therapeutic is loaded in a portion of the outer layer.
NI201600077A2013-12-112016-06-08
PHARMACOLOGICAL ADMINISTRATION SYSTEM
NI201600077A
(en)
Pharmaceutical dosage form with breaking strength of at least 500 n, which contains an active ingredient, an anionic polysaccharide and a polyalkylene oxide, wherein the active ingredient is present in a controlled release matrix comprising the anionic polysaccharide and the oxide of polyalkylene.
Transdermal drug delivery system comprising a drug-containing layer comprising a polymeric matrix containing estradiol as the only drug; production method; useful for administering estradiol.
A method for treating infections, diseases or disorders of the nail unit, with a device for implanting a composition in a given location and a dosage regimen for treating a disease or disorder of the nail unit.
METHOD FOR THE MANUFACTURE OF A DEVICE FOR THE ADMINISTRATION OF DRUGS AND A DEVICE FOR THE ADMINISTRATION OF DRUGS MANUFACTURED IN ACCORDANCE WITH THE METHOD